• Explore /
  • Poster
  • / Phase Ib/IIa trial of CEND‐1 in combination with neoadjuvant FOLFIRINOX-based therapies in pancreatic, colorectal, and appendiceal cancers (CENDIFOX).

Phase Ib/IIa trial of CEND‐1 in combination with neoadjuvant FOLFIRINOX-based therapies in pancreatic, colorectal, and appendiceal cancers (CENDIFOX).

Abstract Poster

Authors

null

Anup Kasi

University of Kansas Cancer Center, Westwood, KS

Anup Kasi , Harri Jarvelainen , Raed Moh'd Taiseer Al-Rajabi , Anwaar Saeed , Milind A. Phadnis , Anusha Chidharla , Timothy Schmitt , Sean Kumer , Mazin Mazin Al-Kasspooles , John Ashcraft , Benjamin Martin , Samuel Luka , Mojtaba Olyaee , Amit Rastogi , Scott James Weir , Subhrajit Saha , Prasad Dandawate , Rashna Madan , Weijing Sun , Joaquina Celebre Baranda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT05121038

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS4195)

DOI

10.1200/JCO.2022.40.16_suppl.TPS4195

Abstract #

TPS4195

Poster Bd #

162b

Abstract Disclosures

Similar Posters

First Author: Sherise C. Rogers

First Author: Sherise C. Rogers

First Author: Marc Van Den Eynde

First Author: Albert Abad